- Home
- ABVX vs FBIN Comparison
ABVX vs FBIN Comparison
Compare ABVX & FBIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABVX
- FBIN
- Stock Information
- Founded
- ABVX 2013
- FBIN 1988
- Country
- ABVX France
- FBIN United States
- Employees
- ABVX N/A
- FBIN N/A
- Industry
- ABVX
- FBIN Building Products
- Sector
- ABVX
- FBIN Consumer Discretionary
- Exchange
- ABVX Nasdaq
- FBIN Nasdaq
- Market Cap
- ABVX 6.7B
- FBIN 7.3B
- IPO Year
- ABVX N/A
- FBIN N/A
- Fundamental
- Price
- ABVX $90.65
- FBIN $50.26
- Analyst Decision
- ABVX Strong Buy
- FBIN Buy
- Analyst Count
- ABVX 9
- FBIN 11
- Target Price
- ABVX $94.11
- FBIN $75.45
- AVG Volume (30 Days)
- ABVX 957.6K
- FBIN 1.3M
- Earning Date
- ABVX 08-11-2025
- FBIN 11-05-2025
- Dividend Yield
- ABVX N/A
- FBIN 1.99%
- EPS Growth
- ABVX N/A
- FBIN N/A
- EPS
- ABVX N/A
- FBIN 3.18
- Revenue
- ABVX $7,073,400.00
- FBIN $4,496,000,000.00
- Revenue This Year
- ABVX $4.44
- FBIN $0.69
- Revenue Next Year
- ABVX N/A
- FBIN $3.15
- P/E Ratio
- ABVX N/A
- FBIN $15.77
- Revenue Growth
- ABVX N/A
- FBIN N/A
- 52 Week Low
- ABVX $4.77
- FBIN $47.21
- 52 Week High
- ABVX $93.77
- FBIN $90.50
- Technical
- Relative Strength Index (RSI)
- ABVX 74.86
- FBIN 31.77
- Support Level
- ABVX $85.00
- FBIN $52.15
- Resistance Level
- ABVX $90.70
- FBIN $54.07
- Average True Range (ATR)
- ABVX 2.98
- FBIN 1.31
- MACD
- ABVX -0.26
- FBIN -0.36
- Stochastic Oscillator
- ABVX 75.33
- FBIN 2.64
About ABVX Abivax SA American
Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.
About FBIN Fortune Brands Innovations Inc.
Fortune Brands Innovations is a leading home and security products company that has three reportable segments. The company's $2.6 billion water segment, led by the Moen brand, sells faucets, showers, and other plumbing fixtures; the $1.4 billion outdoors segment primarily sells entry doors under the Therma-Tru brand name and Fiberon-branded patio decking; and the $700 million security segment sells locks and other security devices under the Master Lock, SentrySafe, Yale, and August brand names.